logo

For the Inventor, By the Inventor

Berlin, Germany

Kirstin Petersen

This inventor holds 17 USPTO granted patents and 16 published patent applications and 12 EPO patents. Top assignees: Bayer Pharma Aktiengesellschaft, Bayer Aktiengesellschaft, Deutsches Krebsforschungszentrum. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kirstin Petersen. Retrieved from https://idiyas.com/inventor/kirstin-petersen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 17 

% Patents Active = 41.2

 

Average Co-Inventor Count = 10.5

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:

goldMedal11 out of 387 
 
Bayer Pharma Aktiengesellschaft
 patents
silverMedal5 out of 12,268 
 
Bayer Aktiengesellschaft
 patents
bronzeMedal4 out of 159 
 
Deutsches Krebsforschungszentrum
 patents
4. 3 out of 721 
 
Bayer Intellectual Property Gmbh
 patents
5. 1 out of 1,268 
 
Dana-Farber-Cancer Institute Inc.
 patents
6. 1 out of 486 
 
The Broad Institute, Inc.
 patents
where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...
Loading Chart...
17 patents (USPTO):Explore Patents
1. 12673927 - SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION (2026-07-07),
2. 12478621 - SUBSTITUTED AMINOQUINOLONES AS DGKALPHA INHIBITORS FOR IMMUNE ACTIVATION (2025-11-25),
3. 11998539 - Substituted aminoquinolones as DGKalpha inhibitors for immune activation (2024-06-04),
4. 11964953 - Substituted aminothiazoles as DGKzeta inhibitors for immune activation (2024-04-23),
5. 11427578 - Substituted pyrrolopyridine-derivatives (2022-08-30),
6. 11339157 - 4H-pyrrolo[3,2-c]pyridin-4-one derivatives (2022-05-24),
7. 10717749 - Macrocyclic sulfondiimine compounds (2020-07-21),
8. 10487092 - Pyrazolopyridinamines as MKNK1 and MKNK2 inhibitors (2019-11-26),
9. 10214545 - Amido-substituted imidazopyridazines useful in the treatment of hyper-proliferative and/or angiogenesis disorders (2019-02-26),
10. 10214542 - Modified macrocyclic compounds (2019-02-26),
11. 9783543 - Aminoimidazopyridazines (2017-10-10),
12. 9777004 - Amino-substituted imidazopyridazines (2017-10-03),
13. 9745304 - Amidoimidazopyridazines as MKNK-1 kinase inhibitors (2017-08-29),
14. 9643974 - Amino-substituted imidazopyridazines (2017-05-09),
15. 9409889 - Amino-substituted imidazopyridazines (2016-08-09),

Title: The Innovative Journey of Inventor Kirstin Petersen in Robotics and Autonomous Systems

Introduction:

Inventor Kirstin Petersen, based in Berlin, DE, is a leading figure whose groundbreaking work continues to inspire the next generation of inventors and researchers in the thrilling realm of robotics and autonomous systems.

Latest Patents:

Petersen's inventive spirit is reflected in his 14 patents, with two recent notable creations standing out:

1. Substituted Aminothiazoles as DGKzeta Inhibitors for Immune Activation: This patent encompasses aminothiazole compounds that hold promise for treating diacylglycerol kinase zeta (DGKζ) regulated disorders, demonstrating his commitment to advancing medical science.

2. Substituted Pyrrolopyridine-Derivatives: This invention focuses on protein-inhibitory substituted pyrrolopyridine derivatives that show potential in addressing neoplastic disorders, cancer, dysregulated immune responses, and various other conditions associated with aberrant MAP4K1 signaling.

Career Highlights:

Petersen's professional journey includes impactful collaborations with renowned companies, notably Bayer Pharma Aktiengesellschaft and Bayer Intellectual Property GmbH. His tenure with these organizations has undoubtedly contributed to his innovative prowess and the development of cutting-edge technologies in the field of robotics and autonomous systems.

Collaborations:

Throughout his career, Petersen has worked closely with accomplished individuals in the industry, including Philip Lienau and Detlev Sülzle. These collaborations have enriched his work and fostered a culture of innovation and excellence in his projects.

Conclusion:

In conclusion, Kirstin Petersen's unwavering dedication to pushing the boundaries of robotics and autonomous systems through his inventive solutions and patent-worthy creations is a testament to his impactful legacy. His pioneering spirit serves as a beacon for aspiring inventors and researchers, inspiring a new wave of innovation in the field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…